Larazotide
Larazotide acetate · AT-1001 · INN-202
An orally administered peptide studied as a regulator of tight junctions in the intestinal epithelium, investigated in trials for celiac disease alongside a gluten-free diet. Reported to act locally in the gut with minimal systemic absorption.
Tracking and educational reference only, on values you enter or import yourself. Not medical advice or a dosing recommendation.
Regulatory status
Investigational
This substance is under study in humans, typically under a regulatory authorization such as an Investigational New Drug application. Investigational describes a stage of research and nothing more: it does not mean approval is coming, and it does not indicate that effectiveness has been established.
A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.
Half-life
Acts locally in the gut; a systemic half-life is not well defined. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; no approved label defines handling.
References
- PubChem compound record
- Am J Physiol Gastrointest Liver Physiol 2021: pharmacological review of larazotide acetate
- Clin Res Hepatol Gastroenterol 2022: systematic review and meta-analysis in celiac disease
Read the source
Common questions
Larazotide, answered plainly.
01What is Larazotide?+
An orally administered peptide studied as a regulator of tight junctions in the intestinal epithelium, investigated in trials for celiac disease alongside a gluten-free diet. Reported to act locally in the gut with minimal systemic absorption. It is also referred to as Larazotide acetate, AT-1001, INN-202. It is listed here under Healing / Recovery as educational reference, which is not a recommendation to use it.
02Is Larazotide FDA approved?+
Investigational. This substance is under study in humans, typically under a regulatory authorization such as an Investigational New Drug application. Investigational describes a stage of research and nothing more: it does not mean approval is coming, and it does not indicate that effectiveness has been established.
03What is the half-life of Larazotide?+
Acts locally in the gut; a systemic half-life is not well defined. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.
04How is Larazotide stored and handled?+
Investigational; no approved label defines handling. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.
Related in Healing / Recovery
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.